NIH-funded research R21 grant

Understanding how HIV-specific IgA sugar tags affect its movement and action

Official title: Assessing the Role of HIV-specific IgA glycosylation on transport and function

Funded at Rush University Medical Center · NIH-11408110 · Data updated 2026-11-12

A study to see how sugar decorations on HIV-targeting IgA antibodies influence where they travel in the body and how well they work against HIV.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionRush University Medical Center
NIH-funded
Lab location1 site (Chicago, United States)
Project startJune 5, 2026
Project endMay 31, 2028
Funding year2026
Award (this year)$269,500
NIH project number1R21AI198095-01A1
Project IDNIH-11408110 on NIH RePORTER

Who could benefit from this research

Could help

People living with HIV from whom IgA antibodies can be collected and analyzed for glycosylation patterns.

Less likely to help

Individuals not yet engaged in research or those without HIV infection or related samples may not directly benefit.

What this research studies

This project will explore how the glycosylation patterns of HIV-specific IgA antibodies affect their transport and effector functions in the body. By analyzing IgA from people living with HIV, the team aims to identify glycosylation features that change how these antibodies move through tissues and engage immune responses. The findings could guide the design of smarter antibody-based approaches to help control HIV infection. The work builds on prior observations about how antibody sugars influence movement across barriers and into lymphoid tissues.

Why it matters

Potential benefit: If successful, the research could inform the development of more effective IgA-based strategies to prevent HIV spread and improve immune control.

How similar studies have gone: Preliminary data suggest that antibody glycosylation can influence transport and function, but direct HIV-specific IgA effects remain under study.

Where this research is happening

  • Rush University Medical Center
    Chicago, United States
    Active

Researchers

  • Principal investigator: Schneider, Jeffrey R — Rush University Medical Center
  • Study coordinator: Schneider, Jeffrey R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.